Article
I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib
12 Feb 2015
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMed